(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Breaking: Archer Aviation Lands Up to $142M in Contracts; Bullish Stance On Apple

July 31st, 2023

Archer Aviation Inc. (NYSE: ACHR) has expanded its partnership with the U.S. Department of Defense (DoD) through new contracts with the U.S. Air Force valued at up to $142 million Archer will deliver up to six of its Midnight aircraft to the Air F. Read more

Earnings Preview: Etsy, Humana, McKesson, and DoorDash in Focus

July 30th, 2023

Some of the companies expected to report their financial results on Wednesday, August 02, are: Etsy, Inc. (Nasdaq: ETSY), a well-known e-commerce platform, plans to release its second quarter 2023 financial results after the market close.  . Read more

Upcoming Earnings: Pinterest, Virgin Galactic, Leidos, and Littelfuse Take the Stage

July 30th, 2023

Several companies are gearing up to report their financial results on Tuesday, August 01, shedding light on their performance and market trends, including: Pinterest, Inc. (NYSE: PINS), a prominent social media platform, will unveil its financial . Read more

Breaking: Citius Pharma Faces Regulatory Setback; Bullish View On First Solar

July 29th, 2023

Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) said that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for its Biologics License Application (BLA). The application sought approval for denileukin diftitox (LYMPHIRTM), . Read more

Key Metrics: Ecolab, AIG, Rockwell Automation, and IQVIA Earnings Due

July 29th, 2023

Several companies are slated to announce their financial results on Tuesday, August 1, giving investors valuable insights into their performance and market trends, including: Ecolab Inc. (NYSE: ECL), a prominent global provider of water, hygiene, . Read more

Earnings On The Horizon: Merck, Pfizer, AMD, and Caterpillar - A Preview

July 28th, 2023

Multiple companies are set to report their financial results on Tuesday, August 1, including: Merck & Co., Inc. (NYSE: MRK), a pharmaceutical giant, is expected to announce its second-quarter 2023 earnings results prior to the market opening. . Read more

PSTT Deal Fuels China Natural Resources; Unique Fabricating Addresses Trading Uptick

July 28th, 2023

Shares of China Natural Resources, Inc. (Nasdaq: CHNR) experienced a remarkable surge of over 50% in after-hours trading following the company's announcement of a deal to sell all outstanding shares of Precise Space-Time Technology Limited (PSTT) to . Read more

President Biden Takes Action: Historic Military Justice Reform

July 28th, 2023

President Biden is set to sign an Executive Order implementing historic bipartisan military justice reforms today, aimed at strengthening the military's handling of sexual assault cases. The Order transfers decision-making authority from commanders t. Read more

DexCom Gains Pre-Market Traction on Financial Figures, Bullish Views

July 28th, 2023

DexCom, Inc. (Nasdaq: DXCM) delivered strong results in the second quarter of 2023, with earnings per share (EPS) of $0.34 and revenues of $871.30 million, surpassing the consensus estimate of $0.23 EPS on revenue of $841.62 million. In response t. Read more

Q2 Earnings: Centene Beats, ArcBest Misses Estimates

July 28th, 2023

Centene Corporation (NYSE: CNC) reported strong second-quarter 2023 adjusted earnings per share (EPS) of $2.10 and revenues of $37.61 billion, exceeding the consensus estimate of $2.03 EPS on revenue of $36.47 billion. In response to the robust pe. Read more